Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vascular Solutions
New activities and developments reported by Vascular Solutions
February 14th, 2007
New activities and developments reported by Vascular Solutions. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Vascular Solutions. Report 1: Vascular Solutions, Inc. (VASC) has received approval from the U.S. Food and Drug Administration (FDA) of its PMA supplement for the added indicated use of the D-Stat Flowable hemostat for reducing the incidence of clinically significant hematomas in the implantation of a pulse generator (pacemaker or ICD) in anticoagulated patients. The D-Stat Flowable hemostat is a thick, yet flowable, suspension of collagen, thrombin and diluent that...
Source: Medical Patent Law Weekly (2007-02-14)
|
